Inactive

Notice of Intent to Sole Source HT941023N0105 THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE NON-PERSONAL SERVICES CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Co... Notice of Intent to Sole Source HT941023N0105 THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE NON-PERSONAL SERVICES CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Western Markets Contracting Division (WMCD), San Diego, intends to negotiate and award a firm fixed price contract for the Aesculap Implant Systems, Aesculap Implant Systems, LLC, in accordance with Federal Acquisition Regulation FAR 13.106-1(b)(1)(i), only one source being available to meet the Government’s needs, to: Aesculap Implant Systems, LLC 3773 Corporate Pkwy Ste. 200 Center Valley, PA 18034-8218 The North American Industry Classification System (NAICS) code for this requirement is 339113 – Surgical and Medical Instrument Manufacturing; the business size standard is 1,250 (# of employees). The Product Service Code (PSC) is 6515 – Medical and Surgical Instruments, Equipment, and Supplies. The objective of this sole source award is to procure two Aesculap lumbar implant systems. Upon evaluation by the surgeon, Aesculap Implant Systems, LLC, was the only market option found for supply of the required implant systems. The requirement will be as follows: CLIN0001: ACTIV L PE-INLAY 8.5MM QTY: 2 Part # SW965 CLIN0002: ACTIV L SUP.PLATE SIZE S 6°/SPIKES QTY: 2 Part # SW971K CLIN0003: ACTIV L INF.PLATE S1 SIZE S 5°/SPIKES QTY: 2 Part # SW976K Based on market research, Aesculap Implant Systems, LLC, is the only source that can meet the Government’s minimum requirements for the Aesculap Implant Systems in support of Naval Medical Center San Diego (NMCSD)’s Neurosurgery Department at NMCSD 34800 Bob Wilson Dr, San Diego CA 92134-5000. The risks of not procuring these supplies are delays in patient care. This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required supplies for Naval Medical Center San Diego (NMCSD)’s Neurosurgery Department. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Gilberto Esteves at gilberto.a.esteves.civ@health.mil. The closing date for challenges is no later than 0900 Pacific Time, 01 September 2023. NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.

Inactive

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency intends to negotiate on a sole source basis (IAW FAR 13.501(a),... THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency intends to negotiate on a sole source basis (IAW FAR 13.501(a), Only One Responsible Source. The proposed source is Roche Diagnostics Corporation, 9915 Hague Rd, Indianapolis, Indiana, 46256-1025. The requirement is for a contract for the lease of two (2) Chemistry analyzers, annual off-site key operator training for each analyzer, purchase of reagents, third party quality controls (Bio-Rad), maintenance service, and consumables for Naval Health Clinic (NHCH). One (1) clinical chemistry/immunoassay analyzer shall be for Branch Health Clinic (BHC) Makalapa, and one (1) clinical chemistry analyzer shall be for BHC Kaneohe Bay. The contracted analyzer for Makalapa shall be a single platform configuration capable of performing general chemistry, immunoassay, and screening for electrolytes, diabetes, hepatic diseases, thyroid diseases, cardiac diseases, renal diseases, and infectious diseases, as defined below. The contracted analyzer for BHC Kaneohe Bay shall be capable of performing general chemistry, and screening for electrolytes, hepatic diseases, renal diseases, and cardiac diseases. The contracted analyzers for each clinic shall be capable of performing the tests listed below at the yearly indicated test volume. The contracted analyzers for BHC Makalapa and BHC Kaneohe Bay shall have the same test methodology to ensure accuracy of results between clinics. The contractor shall be capable of 24-hour response time. The contractor shall be available for telephone troubleshooting consultation 24 hours a day, 7 days a week, 365 days per year, except on Federal holidays. The contract shall include operator training. The contract shall include water purifiers connected to the analyzers, its’ maintenance service, and all consumables. BHC Makalapa Requirements: The contracted analyzer shall be an integrated general chemistry and immunoassay analyzer providing a single footprint that provides Syphilis Antibody testing algorithm. The contracted analyzer shall be capable of completing a minimum of 375 tests per hour. Due to space constraints, the contracted analyzer shall fit within the following dimensions: 70 inches (H) x 98 inches (W) x 32 inches (D). The contracted analyzer shall perform all the analytes at the annual estimated test volume as indicated below. 2022 ANNUAL ESTIMATED TEST VOLUME (REPORTABLE) - BHC MAKALAPA TEST QTY TEST QTY TEST QTY ALBUMIN 4691 CREATININE 5592 POTASSIUM 3901 ALKP 4336 CREATINE KINASE 110 SODIUM 3896 ALT 4314 GGT 417 T3, FREE 83 AST 5338 GLUCOSE 5015 T4, FREE 1058 BICARBONATE 4002 BETA HCG 345 TOTAL PROTEIN 4292 BILIRUBIN, DIRECT 516 HDL 4099 TRIGLYCERIDES 4045 BILIRUBIN, TOTAL 4501 HBA1C 5801 TSH 4922 CALCIUM 4073 LDL 3959 UREA/BUN 5538 CHLORIDE 3895 MAGNESIUM 248 URIC ACID 313 CHOLESTEROL, TOTAL 4134 PHOSPHORUS 426 SYPHILIS SCREEN 1845 URINE CREATININE 1391 BHC Kaneohe Bay Requirements: The contracted general chemistry analyzer shall be capable of completing a minimum of 375 tests per hour. The contracted analyzer shall fit within the following dimensions: 70 inches (H) x 58 inches (W) x 32 inches (D). The contracted analyzer shall perform all the analytes at the annual estimated test volume as indicated below. 2022 ANNUAL ESTIMATED TEST VOLUME (REPORTABLE) - BHC KANEOHE BAY TEST QTY TEST QTY TEST QTY ALBUMIN 2515 CHLORIDE 2190 PHOSPHORUS 181 ALKP 2478 CHOLESTEROL, TOTAL 2166 POTASSIUM 2199 ALT 2373 CREATININE 2598 SODIUM 2190 AST 2594 CREATINE KINASE 100 TOTAL PROTEIN 2357 BICARBONATE 2190 GGT 185 TRIGLYCERIDES 2129 BILIRUBIN, DIRECT 420 GLUCOSE 2889 UREA/BUN 2592 BILIRUBIN, TOTAL 2642 HDL 2151 URIC ACID 142 CALCIUM 2253 LDL 2090 Periods of Performance Base: 01 October 2023 - 30 September 2024 OPT1: 01 October 2024 - 30 September 2025 OPT 2: 01 October 2025 - 30 September 2026 OPT 3: 01 October 2026 - 30 September 2027 OPT 4: 01 October 2027 - 30 September 2028 There are not set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 334516. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF, MS Word, or MS Excel) to Cassi Jo Newman at cassi.j.newman.civ@health.mil Closing date for challenges is no later than 0800 PDT on 05 September 2023. No phone calls will be accepted.